You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API NEVIRAPINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing NEVIRAPINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 CELLULOSE, MICROCRYSTALLINE
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 LACTOSE MONOHYDRATE
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 MAGNESIUM STEARATE
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 POVIDONE
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 SILICON DIOXIDE
State of Florida DOH Central Pharmacy VIRAMUNE nevirapine 53808-0808 SODIUM STARCH GLYCOLATE TYPE A POTATO
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing NEVIRAPINE

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc nevirapine 0378-4050 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc nevirapine 0378-4050 MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc nevirapine 0378-4050 MICROCRYSTALLINE CELLULOSE 101
Mylan Pharmaceuticals Inc nevirapine 0378-4050 MICROCRYSTALLINE CELLULOSE 102
Mylan Pharmaceuticals Inc nevirapine 0378-4050 POVIDONE K30
Mylan Pharmaceuticals Inc nevirapine 0378-4050 SILICON DIOXIDE
Mylan Pharmaceuticals Inc nevirapine 0378-4050 SODIUM STARCH GLYCOLATE TYPE A POTATO
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for NEVIRAPINE

Excipient focus: CARBOMER HOMOPOLYMER TYPE A

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CELLULOSE, MICROCRYSTALLINE

NEVIRAPINE drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Camber Pharmaceuticals Inc nevirapine 31722-505
Macleods Pharmaceuticals Limited nevirapine 33342-004
Micro Labs Limited nevirapine 42571-131
Breckenridge Pharmaceutical Inc nevirapine 51991-331
Cipla Ltd nevirapine 53104-0166
State of Florida DOH Central Pharmacy nevirapine 53808-0680
State of Florida DOH Central Pharmacy nevirapine 53808-0808
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

NEVIRAPINE drug variants containing POVIDONE

Company Ingredient NDC
Camber Pharmaceuticals Inc nevirapine 31722-505
Macleods Pharmaceuticals Limited nevirapine 33342-004
Macleods Pharmaceuticals Limited nevirapine 33342-238
Breckenridge Pharmaceutical Inc nevirapine 51991-331
State of Florida DOH Central Pharmacy nevirapine 53808-0808
Carlsbad Technology Inc nevirapine 61442-470
Strides Pharma Science Limited nevirapine 64380-709
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

NEVIRAPINE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN

Company Ingredient NDC
Mylan Pharmaceuticals Inc nevirapine 0378-4050
Mylan Pharmaceuticals Inc nevirapine 0378-4890
Mylan Pharmaceuticals Inc nevirapine 0378-6950
Sandoz Inc nevirapine 0781-5893
Camber Pharmaceuticals Inc nevirapine 31722-505
Macleods Pharmaceuticals Limited nevirapine 33342-004
Macleods Pharmaceuticals Limited nevirapine 33342-238
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

NEVIRAPINE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Mylan Pharmaceuticals Inc nevirapine 0378-4050
Camber Pharmaceuticals Inc nevirapine 31722-505
Macleods Pharmaceuticals Limited nevirapine 33342-004
Micro Labs Limited nevirapine 42571-131
Cipla Ltd nevirapine 53104-0166
State of Florida DOH Central Pharmacy nevirapine 53808-0680
State of Florida DOH Central Pharmacy nevirapine 53808-0808
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: WATER

Excipient focus: ZINC STEARATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group